Sasha Gusev

sashagusevposts.bsky.social

01 October 2026 04:54

A searchable mapping between NIH study sections and program officers that doesn't suck. (Claude one-shot) sashagusev.github.io/po-study-sec...

Jeffrey Wooldridge

jmwooldridge.bsky.social

30 September 2026 04:57

In case anyone is interested, here is a new working paper on non-binary treatments with staggered interventions. Essentially, I show under what assumptions it is valid to estimate cohort x time dose-response functions. papers.ssrn.com/sol3/papers....

Mike Inouye

mikeinouye.bsky.social

27 September 2026 09:40

📣 It's been a long time coming but delighted to see that the @nejm.org review from David Hunter and me is out! "Clinical Uses of Common Genetic Variants Associated with Common Diseases" www.nejm.org/doi/full/10.... The next 10 years will be a very exciting time for genomic population health

American Journal of Epidemiology

amjepi.bsky.social

22 September 2026 17:46

✨Quarterly Paper Shoutout✨ Every quantitative study should answer one question: What is your estimand? This article shows how to clarify causal estimands—and why doing so matters for actionable, equity-focused evidence. doi.org/10.1093/aje/...

Emil Uffelmann

euffelmann.bsky.social

22 September 2026 11:52

New preprint 🧵 Nagelkerke's R² is widely used to report polygenic score performance for binary traits, but it depends on prevalence and case fraction, so you can't compare it across diseases or studies. We derive a simple conversion to the liability scale. 👇